Jump to content

Lymphatic endothelium

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Caiaffa (talk | contribs) at 03:18, 19 July 2008 (Typo correction - You can help!, Replaced: inflamation → inflammation using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

The lymphatic endothelium is a specialised form of epithelium, distict from but similar to vascular endothelium.

Although lymphatics were first described by Hippocrates in 400BC and rediscovered as "milky veins in the gut of a well fed dog" in the 1600s by Gasparo Aselli, they were ignored for centuries until in 1937 Howard Florey showed that lymphatics enlarge in inflammation. At this stage vascular and lymphatic endothelia were seen to be morphologically distinct and lymphatic vessels considered less important. Later it was discovered that VEGF-R3 and VEGF-C/VEGF-D were the key growth factors controlling lymphatic endothelial proliferation. Markers of lymphatic endolthelium were not discovered until relatively recently. These being LYVE-1 (Jackson et al,1999)[1] and podoplanin (Kerjaschki,199)[2]

References

  1. ^ "J.Cell Biol: LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan 1".
  2. ^ "Am. J. Pathol: Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic andothelium 2".

Further reading